The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy.
Open accessAbstract
Studies conducted over the last decade demonstrated variable therapeutic efficacy of angiotensin converting enzyme (ACE) inhibitor on the progression of glomerular diseases, including IgA nephropathy. In this study, among patients with biopsy-proven IgA nephropathy, 53 patients in whom creatinine clearance had been monitored over 5 yr were recruited for study. These patients were classified into two groups according to whether or not renal function had declined as determined by the slope of creatinine clearance against time: group 1 had stable renal function; group 2 had declining renal function (average: -6.7 +/- 1.3 ml/min/yr). 21 of 53 patients were treated with ACE inhibitor and followed for 48 wk. Gene polymorphism consisting of insertion (I) or deletion (D) of a 287-bp DNA fragment (presumed to be a silencer element) of the ACE gene was determined by PCR. 46 age-matched individuals without history of proteinuria were analyzed as controls. The DD genotype was significantly more frequent in group 2 (43%) than in controls (7%) or group 1 patients with stable renal function (16%). 48 wk after ACE inhibitor administration, proteinuria significantly decreased in patients with DD genotype but not in those with ID or II genotypes. The results indicate that deletion polymorphism in the ACE gene, particularly the homozygote DD, is a risk factor for progression to chronic renal failure in IgA nephropathy. Moreover, this deletion polymorphism predicts the therapeutic efficacy of ACE inhibition on proteinuria and, potentially, on progressive deterioration of renal function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., & Soubrier, F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114844 · Cited by 3,767
Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J.-P., Arveiler, D., Luc, G., Bard, J.-M., Bara, L., Ricard, S., et al. (1992) · Nature · doi:10.1038/359641a0 · Cited by 1,913
Rigat, B., Hubert, C., Corvol, P., & Soubrier, R. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.6.1433-a · Cited by 1,236
Tiret, L., Rigat, B. A., Visvikis‐Siest, S., Breda, C., Corvol, P. L., Cambien, F., & Soubrier, F. (1992) · Europe PMC (PubMed Central) · Cited by 1,174
Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112528 · Cited by 1,072
Lindpaintner, K., Pfeffer, M. A., Kreutz, R., Stampfer, M. J., Grodstein, F., LaMotte, F., Buring, J., & Hennekens, C. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503163321103 · Cited by 899
The Progression of Renal Disease
Epstein, F. H., Klahr, S., Schreiner, G., & Ichikawa, I. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806233182505 · Cited by 828
Self-citationSchunkert, H., Hense, H.-W., Holmer, S. R., Stender, M., Perz, S., Keil, U., Lorell, B. H., & Riegger, G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302302 · Cited by 740
Costerousse, O., Allegrini, J., Lopez, M., & Alhenc-Gelas, F. (1993) · Biochemical Journal · doi:10.1042/bj2900033 · Cited by 507
Hubert, C., Houot, A. M., Corvol, P., & Soubrier, F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98626-6 · Cited by 426
Raynolds, M. V., Bristow, M. R., Bush, E. W., Abraham, W. T., Lowes, B. D., Zisman, L. S., Taft, C. S., & Perryman, M. B. (1993) · The Lancet · doi:10.1016/0140-6736(93)92061-w · Cited by 413
Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death
MARIAN, A. (1993) · The Lancet · doi:10.1016/0140-6736(93)92064-z · Cited by 409
Bjorck, S., Nyberg, G., Mulec, H., Granerus, G., Herlitz, H., & Aurell, M. (1986) · BMJ · doi:10.1136/bmj.293.6545.471 · Cited by 405
Marre, M., Bernadet, P., Gallois, Y., Savagner, F., Guyene, T.-T., Hallab, M., Cambien, F., Passa, P., & Alhenc-Gelas, F. (1994) · Diabetes · doi:10.2337/diab.43.3.384 · Cited by 366
Linz, W., Schölkens, B. A., & Ganten, D. (1989) · Clinical and Experimental Hypertension. Part A: Theory and Practice · doi:10.3109/10641968909038172 · Cited by 336
Parving, H. H., Hommel, E., & Smidt, U. M. (1988) · BMJ · doi:10.1136/bmj.297.6656.1086 · Cited by 328
Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.
Hommel, E., Parving, H. H., Mathiesen, E., Edsberg, B., Damkjaer Nielsen, M., & Giese, J. (1986) · BMJ · doi:10.1136/bmj.293.6545.467 · Cited by 308
Alamartine, E., Sabatier, J.-C., Guerin, C., Berliet, J.-M., & Berthoux, F. (1991) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80284-8 · Cited by 283
Zee, R. Y. L., Lou, Y.-K., Griffiths, L. R., & Morris, B. J. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91150-o · Cited by 261
Tiret, L., Nicaud, V., Kee, F., Evans, A., Cambou, J. P., Arveiler, D., Luc, G., Amouyel, P., Poirier, O., Lecerf, L., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)91075-w · Cited by 254
IgA nephropathy, the most common glomerulonephritis worldwide
Julian, B. A., Waldo, F. B., Rifai, A., & Mestecky, J. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90019-8 · Cited by 242
Doria, A., Warram, J. H., & Krolewski, A. S. (1994) · Diabetes · doi:10.2337/diab.43.5.690 · Cited by 191
Schmidt, S., van Hooft, I. M. S., Grobbee, D. E., Ganten, D., & Ritz, E. (1993) · Journal of Hypertension · doi:10.1097/00004872-199304000-00003 · Cited by 188
Cattran, D. C., Greenwood, C., & Ritchie, S. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80980-2 · Cited by 172
Kakinuma, Y., Kawamura, T., Bills, T., Yoshioka, T., Ichikawa, I., & Fogo, A. (1992) · Kidney International · doi:10.1038/ki.1992.259 · Cited by 159
Self-citationAngiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy
Remuzzi, A., Perticucci, E., Ruggenenti, P. L., Mosconi, L., Limonta, M., & Remuzzi, G. (1991) · Kidney International · doi:10.1038/ki.1991.160 · Cited by 145
Bohn, M., Berge, K. E., Bakken, A., Erikssen, J., & Berg, K. (1993) · Clinical Genetics · doi:10.1111/j.1399-0004.1993.tb03903.x · Cited by 116
Toward individual prognosis of IgA nephropathy
Beukhof, J. R., Kardaun, O., Schaafsma, W., Poortema, K., Donker, A. M., Hoedemaeker, P. J., & van der Hem, G. K. (1986) · Kidney International · doi:10.1038/ki.1986.33 · Cited by 110
Clozel, J., Kühn, H., & Hefti, F. (1989) · Journal of Hypertension · doi:10.1097/00004872-198904000-00005 · Cited by 104
Slomowitz, L. A. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812083192312 · Cited by 61
Rekola, S., Bergstrand, A., & Bucht, H. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000186518 · Cited by 58
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
(1994) · New England Journal of Medicine · doi:10.1056/nejm199401133300225 · Cited by 55
Detection of abnormal peripheral blood mononuclear cell cytokine networks in human IgA nephropathy
de Caestecker, M. P., Bottomley, M., Telfer, B. A., Hutchinson, I. V., Vose, B. M., & BALLARDIE, F. W. (1993) · Kidney International · doi:10.1038/ki.1993.382 · Cited by 47
Angiotensin-converting enzyme gene polymorphism in haemodialysis patients
Nomura, H., Koni, I., Michishita, Y., Morise, T., & Takeda, R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92728-6 · Cited by 41
Cited by
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
Evans, W. E., & Relling, M. V. (1999) · Science · doi:10.1126/science.286.5439.487 · Cited by 2,475
Angiotensin-Converting Enzyme Inhibitors
Brown, N. J., & Vaughan, D. E. (1998) · Circulation · doi:10.1161/01.cir.97.14.1411 · Cited by 958
Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors
D’Amico, G. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.8966 · Cited by 499
Predicting renal outcome in IgA nephropathy.
Radford, M. G., Donadio, J. V., Bergstralh, E. J., & Grande, J. P. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v82199 · Cited by 440
Nabel, E. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035098 · Cited by 431
Metadata
- Authors
- Yoshida, H., Mitarai, T., Kawamura, T., Kitajima, T., Miyazaki, Y., Nagasawa, R., Kawaguchi, Y., Kubo, H., Ichikawa, I., & Sakai, O.
- Venue
- Journal of Clinical Investigation
- Published
- 1995-11-01
- Volume
- 96
- Issue
- 5
- Pages
- 2162-2169
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2027524654
- Cited by
- 322
- References
- 35
- FWCI
- 26.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.